Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU.
Clinical trial NCT05827536 · TERMINATED
Trial details
- NCT number
- NCT05827536
- Sponsor
- APR Applied Pharma Research s.a.
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-30
- Primary completion
- 2024-11-27
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.